Your browser doesn't support javascript.
Safe and effective pool testing for SARS-CoV-2 detection.
Wunsch, Marie; Aschemeier, Dominik; Heger, Eva; Ehrentraut, Denise; Krüger, Jan; Hufbauer, Martin; Syed, Adnan S; Horemheb-Rubio, Gibran; Dewald, Felix; Fish, Irina; Schlotz, Maike; Gruell, Henning; Augustin, Max; Lehmann, Clara; Kaiser, Rolf; Knops, Elena; Silling, Steffi; Klein, Florian.
  • Wunsch M; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany; University of Cologne, Center for Molecular Medicine Cologne, Robert-Koch-Straße 21, 50931 Cologne, Germany.
  • Aschemeier D; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany.
  • Heger E; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany.
  • Ehrentraut D; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Straße 26, 50931 Cologne, Germany.
  • Krüger J; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Straße 26, 50931 Cologne, Germany.
  • Hufbauer M; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany.
  • Syed AS; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany.
  • Horemheb-Rubio G; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, 14080, Mexico.
  • Dewald F; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany; University of Cologne, Center for Molecular Medicine Cologne, Robert-Koch-Straße 21, 50931 Cologne, Germany.
  • Fish I; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany.
  • Schlotz M; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany; University of Cologne, Center for Molecular Medicine Cologne, Robert-Koch-Straße 21, 50931 Cologne, Germany.
  • Gruell H; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany; University of Cologne, Center for Molecular Medicine Cologne, Robert-Koch-Straße 21, 50931 Cologne, Germany.
  • Augustin M; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Kerpener Str. 62, 50937 Cologne, Germany.
  • Lehmann C; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Kerpener Str. 62, 50937 Cologne, Germany.
  • Kaiser R; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany.
  • Knops E; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany.
  • Silling S; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany.
  • Klein F; University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute of Virology, Fürst-Pückler-Straße 56, 50935 Cologne, Germany; University of Cologne, Center for Molecular Medicine Cologne, Robert-Koch-Straße 21, 50931 Cologne, Germany. Electronic address: florian.klein@uk-koeln.
J Clin Virol ; 145: 105018, 2021 12.
Article in English | MEDLINE | ID: covidwho-1487824
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

OBJECTIVES:

The global spread of SARS-CoV-2 is a serious public health issue. Large-scale surveillance screenings are crucial but can exceed test capacities. We (A) optimized test conditions and (B) implemented pool testing of respiratory swabs into SARS-CoV-2 diagnostics. STUDY

DESIGN:

(A) We determined the optimal pooling strategy and pool size. In addition, we measured the impact of vortexing prior to sample processing, compared a pipette-pooling method (by combining transport medium of several specimens) and a swab-pooling method (by combining several swabs into a test tube filled with PBS) as well as determined the sensitivities of three PCR assays. (B) Finally, we applied high-throughput pool testing for diagnostics.

RESULTS:

(A) In a low prevalence setting, we defined a preferable pool size of ten in a two-stage hierarchical pool testing strategy. Vortexing of swabs (n = 33) increased cellular yield by a factor of 2.34. By comparing Ct-values of 16 pools generated with two different pooling strategies, pipette-pooling was more efficient compared to swab-pooling. Measuring dilution series of 20 SARS-CoV-2 positive samples in three PCR assays simultaneously revealed detection rates of 85% (assay I), 50% (assay II), and 95% (assay III) at a 1100 dilution. (B) We systematically pooled 55,690 samples in a period of 44 weeks resulting in a reduction of 47,369 PCR reactions.

CONCLUSIONS:

For implementing pooling strategies into high-throughput diagnostics, we recommend utilizing a pipette-pooling method, performing sensitivity validation of the PCR assays used, and vortexing swabs prior to analyses. Pool testing for SARS-CoV-2 detection is feasible and effective in a low prevalence setting.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: J Clin Virol Journal subject: Virology Year: 2021 Document Type: Article Affiliation country: J.jcv.2021.105018

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: J Clin Virol Journal subject: Virology Year: 2021 Document Type: Article Affiliation country: J.jcv.2021.105018